Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Penciclovir 1% cream
1310030L0AAAAAA
|
Penciclovir | Penciclovir | Skin | 43 |
|
Hydrogen peroxide 3% solution
1311060I0AAABAB
|
Hydrogen peroxide (Topical Cleanser) | Hydrogen peroxide | Skin | 42 |
|
Sterets Tisept solution 25ml sachets
1311020L0BRABAX
|
Sterets Tisept | Chlorhexidine gluconate | Skin | 42 |
|
Dithrocream 0.25% cream
1305020F0BIAABK
|
Dithrocream | Dithranol | Skin | 41 |
|
Lamisil AT 1% cream
131002030BBABAA
|
Lamisil (Topical) | Terbinafine hydrochloride | Skin | 41 |
|
Bazuka Treatment gel
1307000M0BXACAV
|
Bazuka | Salicylic acid | Skin | 40 |
|
Chlorhexidine hydrochloride 0.5% cream
1310050W0AAAAAA
|
Chlorhex hydrochloride | Chlorhex hydrochloride | Skin | 40 |
|
Dimeticone 4% cutaneous spray
1310040V0AAAEAE
|
Dimeticone (Parasiticidal) | Dimeticone (Parasiticidal) | Skin | 40 |
|
Salicylic acid 2% in Aqueous cream
1305020S0AACSCS
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 40 |
|
Zinc undecenoate 20% / Undecenoic acid 5% cream
1310020Z0AAADAD
|
Zinc undecenoate | Undecenoates | Skin | 40 |
|
Tolnaftate 1% liquid spray
1310020Y0AAAPAP
|
Tolnaftate | Tolnaftate | Skin | 38 |
|
Ultrasun Family lotion SPF 30
130801000BBPFA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 38 |
|
Arachis oil liquid
1309000G0AAAAAA
|
Arach oil (scalp) | Arachis oil | Skin | 37 |
|
Aveeno Daily moisturising lotion with lavender
130201000BBLKA0
|
Proprietary compound emollients | Other emollient preparations | Skin | 37 |
|
Dermablend setting powder
130802000BBDHA0
|
Proprietary compound preparation BNF 1308020 | Other camouflage preparations | Skin | 37 |
|
Aveeno Daily moisturising hand cream
130201000BBMHDQ
|
Proprietary compound emollients | Other emollient preparations | Skin | 36 |
|
Clarelux 500micrograms/g foam
1304000G0BDAACC
|
Clarelux | Clobetasol propionate | Skin | 36 |
|
Ultrasun anti-ageing face cream SPF 30
130801000BBPHA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 36 |
|
Catephen 10% ointment
1307000W0BBAAAA
|
Catephen | Camellia sinensis extract | Skin | 35 |
|
Elave shampoo
130201100BBBCA0
|
Proprietary compound preparation BNF 1302011 | Emollient bath and shower preparations | Skin | 35 |
|
Glutarol 10% cutaneous solution
1307000F0BBAAAA
|
Glutarol | Glutaraldehyde | Skin | 34 |
|
Zinc and Salicylic acid paste
1305020S0AACUCU
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 34 |
|
BioBag 50 2.5cm x 4cm dressing kit
1311070S0BDAEAA
|
BioBag | Ster larvae | Skin | 33 |
|
Coal tar and Salicylic acid ointment BP
1305020C0AAFLFL
|
Coal tar/tar (Topical) | Tars | Skin | 33 |
|
Canesten Athlete's Foot 1% cream
1310020H0BBAEAB
|
Canesten (Topical) | Clotrimazole | Skin | 32 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.